drug: memantine |
|
|
| Clinical class | nootropic |
| Action | glutamate antagonist, NMDA antagonist |
| Chemical class | cyclic amine |
| CSA schedule | none |
| DEA number | none |
| Routes of administration | oral |
| Associated with (substance-related)
|
disorders: none |
| Availability | prescription |
U.S. Preparations:
-
Namenda™ (Forest Laboratories) FDA approved for: treatment of moderate to severe Alzheimer's Disease 10.16.2003
Prescribing Information
Preparations Outside U.S.:
- Auxura® (Merz Pharmaceuticals)
- Akatinol, Exiba, Neuroplus